Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Jaime P Almandoz"'
Autor:
Paola Lockhart Pastor, Amin Amin, Daniel Galvan, Ofelia Negrete Vasquez, Jaime P. Almandoz, Ildiko Lingvay
Publikováno v:
Obesity Science & Practice, Vol 10, Iss 3, Pp n/a-n/a (2024)
Abstract Objective Excess adiposity represents a risk factor for chronic kidney disease (CKD) and progression to end‐stage kidney disease. Anti‐Obesity Medications (AOMs) are vastly underutilized in patients with advanced CKD because of concerns
Externí odkaz:
https://doaj.org/article/5d40275c82344b078f2e0b4e2672bddb
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/3b7f1de142ac4676b3b95ca4a5b21595
Autor:
Natia Murvelashvili, Luyu Xie, Jeffrey N. Schellinger, M. Sunil Mathew, Elisa Morales Marroquin, Ildiko Lingvay, Sarah E. Messiah, Jaime P. Almandoz
Publikováno v:
Obesity. 31:1280-1289
Publikováno v:
Obesity. 31:329-337
Autor:
Olivia Kapera, Luyu Xie, Elisa M. Marroquín, Sophia Ngenge, M. Sunil Mathew, Jaime P Almandoz, Jeffrey Schellinger, Sachin S. Kukreja, Benjamin Schneider, Carrie McAdams, Sarah E. Messiah
Publikováno v:
Obesity Surgery. 33:879-889
Purpose. Metabolic and bariatric surgery (MBS) is an evidence-based safe, effective treatment for obesity. However, only half of referred or eligible persons complete the procedure for unknown reasons. The proposed study examined the association betw
Autor:
Sophia Ngenge, Luyu Xie, Carrie McAdams, Jaime P. Almandoz, M. Sunil Mathew, Jeffrey N. Schellinger, Olivia Kapera, Elisa Marroquin, Jackson Francis, Sachin Kukreja, Benjamin E. Schneider, Sarah E. Messiah
Publikováno v:
Obesity Surgery.
Autor:
Karl Nadolsky, Brandi Addison, Monica Agarwal, Jaime P. Almandoz, Melanie D. Bird, Michelle DeGeeter Chaplin, W. Timothy Garvey, Theodore K. Kyle
Publikováno v:
Endocrine Practice.
Autor:
Sarah E. Messiah, Luyu Xie, Matthew Sunil Mathew, Elisa Marroquin Marroquín, Jaime P. Almandoz, Faisal G. Qureshi, Benjamin E. Schneider, Nestor de la Cruz-Muñoz
Publikováno v:
Obesity Surgery. 32:2289-2298
Metabolic and bariatric surgery (MBS) is a safe and effective treatment option for severe obesity. The utilization and health and safety outcomes of MBS in the United States (US) during the COVID-19 pandemic versus 2015-2019 among adolescent and adul
Autor:
Matthew W Segar, Jaime P. Almandoz, Salvatore Carbone, Corby K. Martin, Nitin Kondamudi, Ambarish Pandey, Ian J. Neeland, Javed Butler, Tiffany M. Powell-Wiley, Kershaw V. Patel, Carl J. Lavie
Publikováno v:
Circulation
Background: Obesity and diabetes are associated with a higher risk of heart failure (HF). The interrelationships between different measures of adiposity—overall obesity, central obesity, fat mass (FM)—and diabetes status for HF risk are not well-
Autor:
Luyu Xie, Jaime P. Almandoz, M. Sunil Mathew, Jeffrey N. Schellinger, Olivia Kapera, Sophia Ngenge, Elisa Morales Marroquin, Carrie McAdams, Sachin Kukreja, Benjamin Schneider, Sarah E. Messiah
Publikováno v:
JAMA network open. 5(12)
ImportanceMetabolic and bariatric surgery (MBS) is an effective and safe treatment for obesity and its comorbidities, but less than 50% of those who are eligible and referred for MBS complete the procedure. The patient-physician relationship could be